肝肾综合征

肝肾综合征患者血浆白三烯C4检测及其作用

Measurement and Action of Plasma Leukotriene C_4 in Patients with Hepatorenal syndrome

Cox回归分析对肝肾综合征预后因素的评估

Cox regression analysis of predictive factors of hepatorenal syndrome

治疗组中肝肾综合征的发生率明显低于对照组（P0.05）。

The incidence rate of hepatorenal syndrome in treatment group was obviously lower than that in control group ( P0.05 ) .

目的：观察肝肾综合征（HRS）、失代偿性肝硬化病人血浆白三烯C4（LTC4）的水平及其与肾功能损害的关系。

Aim : To observe the relationship between the level of Plasma leukotriene C4 and re-nal function .

目的：延缓肝肾综合征（HRS）进一步发展，提高病人生存率。

Objective : To stave more progress of HRS and increase survival rate of patient .

4例合并肝肾综合征（HRS）患者中，2例经MARS治疗病情好转，肾功能改善。

Two of 4 patients with hepatorenal syndrome ( HRS ) were improved and cured after treatment with MARS .

目的探讨影响肝肾综合征（HRS）预后的参数及最佳预后指标。

Objective To investigate the predictive factors and the best prognostic parameter of hepatorenal syndrome ( HRS ) .

肝肾综合征（HRS）是严重肝病常见并发症，病死率极高。

Hepatorenal syndrome ( HRS ) is a common complication of serious liver disease with a very high mortality .

lipoPGE1治疗肝肾综合征的疗效观察

Effect of Lipo PGE_1 on HRS

目的：探讨血清、尿视黄醇结合蛋白（retinolbindingprotein，RBP）水平在肝肾综合征鉴别诊断中的价值。

Objective : To investigate the differential diagnostic value of serum retinol binding protein ( RBP ) and urinary RBP in patients with hepatorenal syndrome ( HRS ) .

肝肾综合征组AT、TTP较肝硬化失代偿组进一步延长，PI进一步降低（P<0.05）。

In HRS group , AT and TTP increased and PI decreased even more than those in decompensated patients group ( P < 0.05 ) .

目的肝肾综合征（hepatorenalsyndrome，HRS）是各种肝病晚期的严重并发症，死亡率很高，预后极差，目前尚无有效的治疗措施。

Objectives Hepatorenal syndrome is a severe complication of end-stage liver diseases . Its mortality rate is very high . The prognosis of hepatorenal syndrome is dismal .

病死组血清胆红素水平、HBVdna阳性率、肝性脑病、电解质紊乱、肝肾综合征、上消化道出血、继发感染发生率明显高于好转或治愈组（P0.01）；

In death group , serum bilirubin level , appearance of HBV DNA positive , hepatic encephalopathy , gastrointestinal hemorrhage , hepatorenal syndrome and secondary infection were higher than that in improvement group ( P0.01 ) .

肝肾综合征患者尿TXB2、6-Keto-PGF（1）α测定的临床意义

Measurement of Urinary TXB 2,6 Keto PGF 1 α in Patients with Hepatorenal Syndrome and Its Clinical Significance

结论TIPSS手术可明显改善肝硬化腹水患者肾血流灌注和肾功能，并可成为治疗肝肾综合征（HRS）的有效手段，而对于肝硬化无腹水患者的肾血流动力学及肾功能则无明显影响。

Conclusions The renal hemodynamics in patients with ascites was markedly improved after TIPSS , but there were no changes in patients without ascites .

目的研究肝肾综合征（HRS）病人及其肾功能恢复后的血清促红细胞生成素（EPO）水平的变化，了解血清EPO水平变化在HRS中的临床意义。

Objective To study the changes of the serum erythropoietin ( EPO ) levels in patients with hepatorenal syndrome ( HRS ) and its clinic significance in HRS .

对肝性脑病、肝肾综合征患者，CRRT可改善神志及肾功能，延长存活时间，为行肝移植赢得时间。

CRRT is helpful for restoration of consciousness in patients with hepatic encephalopathy and hepato-renal syndrome and prolong the survival time so that they can win time for the organ transplantation .

7例肝性脑病、肝肾综合征及4例多脏器衰竭者经CRRT治疗后，2例肝昏迷者神志恢复，4例肾功改善，治疗中生命体征稳定。

Two patients restored consciousness and the renal function of 4 cases was improved with stable vital signs after CRRT in 7 cases with hepatic encephalopathy , hepato-renal syndrome and 4 cases with multiple organ failure .

二组间在上消化道出血发生率（4/11vs1/24）差异有统计学意义（P<0.01），而在食道静脉曲张（EV）、胸腹水、肝肾综合征、肝性脑病的发生率差异无统计学意义（P>0.05）；

There was significant difference in upper digestive tract hemorrhage ( 4 / 11 vs 1 / 24 ; P < 0.01 ), but no difference in esophageal varices ( EV ), hydrothorax and ascites , hepatorenal syndrome , hepatic encephalopathy ( P > 0.05 ) between these two groups ;

腹水回输治疗肝肾综合征16例

Treatment of 16 Patients with Hepatorenal Syndrome by Ascites Back Transfusion

肝肾综合征患者血浆心钠素水平的变化

Plasma levels of atrial natriuretic peptide in patients with hepatorenal syndrome

奥曲肽联合多巴胺治疗肝肾综合征的临床研究

Clinical Research on Hepatorenal Syndrome Treated by Octreotide Combined with Dopamine

肝肾综合征诊断要点有哪些？

What does liver kidney ask for diagnostic point integratedly to have ?

1治疗肝肾综合征的临床研究。

Clinical study of patients with hepatorenal syndrome treated with Lipo pge1 .

同时观察肝肾综合征发生情况。

At the same time , the rate of liver-renal syndrome was diagnosed .

从五脏相关学说认识肝肾综合征

Recognition on Liver-spleen Syndrome by Correlative Zang-fu Viscera Doctrine

肝肾综合征2例，积极保肝治疗后痊愈；

Cases of liver kidney syndrome recovered by protecting the liver function actively ;

肿瘤坏死因子-α增强肝肾综合征时肾脏I型1,4,5-三磷酸肌醇受体表达

Tumor necrosis factor - α enhances the expression of type 1 inositol 1,4,5-triphosphate receptors

目的：研究用腹水回输方法综合治疗肝肾综合征的疗效。

Objective : To study the effectiveness of ascites back transfusion treating hepatorenal syndrome .

肝肾综合征病人血清促红细胞生成素水平的测定及其临床意义

Detection of serum erythropoietin level in patients with hepatorenal syndrome and its clinic significance